Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Jammbe_Musoro
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Jammbe_Musoro
-
Jammbe Musoro proslijedio/la je Tweet
New international standards for statistical analysis of
#PROs in#RCTs!@andrewbottom0@madeline_pe@EthanBasch1@pkluetz@drmelcalvert@mold01@Jammbe_Musoro@KathyOliverIBTAhttps://twitter.com/eortc/status/1223051654762835969 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
Excited to present at this meeting and advocate our
@EORTC_QLG agile measurement using our QoL questionnaires and the#Itemlibrary Central =#patientvoice!#cancer#QoLhttps://twitter.com/EORTC_QLG/status/1189429525836435457 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
We are pleased to announce Interstellar 4.0 (Voyager), the latest version of our app. 12 new languages, new UI, improved security, improved trading UI, powerful SEP6 & SEP10 support, the All Spark & more!Available online at https://bit.ly/2JrEIZU . Mobile & desktop apps to followpic.twitter.com/9Cfm8Myd1O
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
Congratulations Corneel for sharing the SISAQOL work. Its been a great collaboration and special thanks to ISOQOL for being a partner of SISAQOL. We cant wait for the main paper to come out in Lancet Oncology soon.
#ISOQOL19@BiostatGirl@EthanBasch1@EORTC_QLG@drkimcockshttps://twitter.com/EORTC/status/1187051571659640832 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
Do not miss "The 18-year-old trial inclusion limit is a major barrier in the access to clinical trials for adolescents and young adults (AYAs) with
#cancer" poster presentation of Dr. de Rojas at 6:30PM#SIOP2019@EORTC@SIOPEuropepic.twitter.com/qTNZP7q0c3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
#SISAQOL poster reporting standardized statistical analysis for#patientreportedoutcomes in an#RCT. Looking forward the published finalized recommendations very soon!@EORTC_QLG@andrewbottom0@madeline_pe#ISOQOL19#HRQL https://event.eortc.org/sisaqol2019/ pic.twitter.com/BvS0Ga5MOO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
Dagmara Kulis: Developing a comprehensible and translatable questionnaire for cognitively vulnerable populations requires a rigorous process involving various experts, patients and proxies.
@szelmowska#ISOQOL19pic.twitter.com/9OzftAjWNl
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
EORTC QLQ-F17 is now available, enabling users to measure functioning scales from the QLQ-C30 with other EORTC modules, item lists and other measurement systems.
@mold01@szelmowska#ISOQOL19pic.twitter.com/IdeYsYtZGQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
“Improving standards of patient reported outcomes analysis: matching statistical methods to key research objectives – a SISAQOL initiative”, watch Corneel Coens' itw,
@EORTC Lead Statistician and meet him @ 3:25 PM (GMT-7)#ISOQOL2019@EORTC_QLG
https://youtu.be/WsXWtrq0uKo pic.twitter.com/JytlRtt4Oi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
Watch Dagmara Kulis
@szelmowska@EORTC QOL Translation Team Leader, talk about her poster: “Road to comprehensibility: development and translation of the EORTC IADL-BN32 questionnaire” Meet her @ 3:25 PM (GMT-7)#ISOQOL2019@EORTC_QLG
https://youtu.be/R9EMczHCnGU pic.twitter.com/G3a1VDAOdQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
Prof Bernhard Holzner: Can using PRO measures improve agreement of CTCAE ratings among clinicians?
#ISOQOL19pic.twitter.com/kLSs6SX5h1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
There is no single global standard for clinically meaningful change across
@EORTC QLQ-C30 scales and across disease sites. Be thoughtful when choosing MIDs.@EORTC@jammbe_musoro#ISOQOL19pic.twitter.com/oONomctRg5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
Claire Piccinin,
@EORTC QOL Researcher, will talk about “Seeking a Mutual Understanding of Health-Related Quality of Life Domains: Mapping the EORTC QLQ-C30 onto the WHO-ICF” Interested? Meet her @ 3:35 PM (GMT-7)#ISOQOL2019@EORTC_QLG
https://youtu.be/kfLlSxpI1lc pic.twitter.com/66fxrhTSkf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
@Jammbe_Musoro@EORTC statistician talks about his oral presentation “Establishing anchor-based minimally important differences for the EORTC QLQ-C30 scales across multiple cancer sites” His presentation is@2:45 PM (GMT-7)#ISOQOL2019@EORTC_QLG
http://youtu.be/mOBl3ZesxhM pic.twitter.com/bRyWiNbP9X
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
EU GDPR improves protection of patients’ data privacy, but data access for secondary
#HRQOL research becomes a challenge. Plan sufficient time & resources.#isoqol2019@EORTC@madeline_pe@Jammbe_Musoropic.twitter.com/bQnvovAz6q
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
@madeline_pe@EORTC Specialist in#QOL will present her poster @ 3:20 PM (GMT-7) She will talk about the CATAPULT experience, the challenge of using health-related QOL data from cancer clinical trials for retrospective studies#ISOQOL2019@EORTC_QLG
https://youtu.be/IbtcUBconC0 pic.twitter.com/ofCVNhVoPo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
Hello
@ISOQOL!@EORTC team is here and preparing for#isoqol19! Looking forward!
@szelmowska@Jammbe_Musoropic.twitter.com/RcVj9qOtjH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
Recent presentations on QOL. Take a look at the entire EORTC QOL conference presentations: all you need to know about QOL and cancer trials. Thanks to all the speakers for https://eortc.meta-dcr.com/qol2019/library
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
#ISCB40 “Extending generalized pairwise comparisons to competing risks allows the analysis of clinical trials in such context with a method providing a global assessment of the treatment effect based on multiple treatment aspects of prime importance to the patients.”@EORTCpic.twitter.com/yUXAE0QEFj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jammbe Musoro proslijedio/la je Tweet
New deadline: 20 July - Help
@EORTC enhancing collaboration within Europe to improve cancer research, fill in this
survey about “Cross-border access to clinical trials in Europe” :
https://bit.ly/2Z6q3bD
#CancerResearch@EFGCP@KU_Leuven@EFPIA and Patvocatespic.twitter.com/fWWz2rvFug
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.